Cargando…

Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasis

BACKGROUND: Evidence of the comparative effectiveness of biological therapies for psoriasis on health‐related quality of life (HRQoL) in routine clinical practice is limited. OBJECTIVES: To examine the comparative effectiveness of adalimumab, etanercept and ustekinumab on HRQoL in patients with psor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iskandar, I.Y.K., Ashcroft, D.M., Warren, R.B., Lunt, M., McElhone, K., Smith, C.H., Reynolds, N.J., Griffiths, C.E.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487951/ https://www.ncbi.nlm.nih.gov/pubmed/28369707 http://dx.doi.org/10.1111/bjd.15531

Ejemplares similares

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
por: Yiu, Z.Z.N., et al.
Publicado: (2018)

Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort study
por: Rungapiromnan, W., et al.
Publicado: (2019)

Persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review
por: Mason, K.J., et al.
Publicado: (2019)

Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
por: Iskandar, Ireny Y.K., et al.
Publicado: (2018)

A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real‐world populations in psoriasis
por: Yiu, Z.Z.N., et al.
Publicado: (2019)

Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta‐analysis of randomized controlled trials
por: Rungapiromnan, W., et al.
Publicado: (2017)

Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy
por: Yiu, Z.Z.N., et al.
Publicado: (2019)

Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR)
por: Mahil, S.K., et al.
Publicado: (2019)

Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study
por: Warren, R.B., et al.
Publicado: (2018)

Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms
por: Warren, RB, et al.
Publicado: (2009)

Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis
por: Thorneloe, R.J., et al.
Publicado: (2016)

Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
por: Yiu, Zenas Z.N., et al.
Publicado: (2018)

The global state of psoriasis disease epidemiology: a workshop report
por: Griffiths, C.E.M., et al.
Publicado: (2017)

Incidence, prevalence and mortality of patients with psoriasis: a U.K. population‐based cohort study
por: Springate, D.A., et al.
Publicado: (2016)

Double-blind, placebo-controlled pilot trial of L-Leucine-enriched amino-acid mixtures on body composition and physical performance in men and women aged 65–75 years
por: Ispoglou, T, et al.
Publicado: (2016)

Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis: A Study From the British Association of Dermatologists Biologics and Immunomodulators Register
por: Yiu, Zenas Z. N., et al.
Publicado: (2020)

National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study
por: Parisi, Rosa, et al.
Publicado: (2020)

Fertility Trends and Adverse Pregnancy Outcomes in Female Patients With Psoriasis in the UK
por: Chen, Teng-Chou, et al.
Publicado: (2023)

Primary care‐based screening for cardiovascular risk factors in patients with psoriasis
por: Rutter, M.K., et al.
Publicado: (2016)

Polymorphisms in the PTPN22 region are associated with psoriasis of early onset
por: Smith, RhLl, et al.
Publicado: (2008)

Risk of COVID‐19 infection in adult patients with atopic eczema and psoriasis: a single‐centre cross‐sectional study
por: Yiu, Z.Z.N., et al.
Publicado: (2021)

Network meta‐analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion method
por: Mrowietz, U., et al.
Publicado: (2021)

Twelve‐week secukinumab treatment is consistently efficacious for moderate‐to‐severe psoriasis regardless of prior biologic and non‐biologic systemic treatment: Post hoc analysis of six randomised trials
por: Hampton, P., et al.
Publicado: (2021)

Risk of Serious Infections in Patients with Psoriasis on Biologic Therapies: A Systematic Review and Meta-Analysis
por: Yiu, Zenas Z.N., et al.
Publicado: (2016)

How Political Science Can Contribute to Public Health: A Response to Gagnon and Colleagues
por: Kothari, Anita, et al.
Publicado: (2017)

Impact of Copy Neutral Loss of Heterozygosity and Total Genome Aberrations on Survival in Myelodysplastic Syndrome
por: Yeung, Cecilia, et al.
Publicado: (2017)

Recovery of Degraded-Beyond-Recognition 19(th) Century Daguerreotypes with Rapid High Dynamic Range Elemental X-ray Fluorescence Imaging of Mercury L Emission
por: Kozachuk, Madalena S., et al.
Publicado: (2018)

Author Correction: Recovery of Degraded-Beyond-Recognition 19(th) Century Daguerreotypes with Rapid High Dynamic Range Elemental X-ray Fluorescence Imaging of Mercury L Emission
por: Kozachuk, Madalena S., et al.
Publicado: (2018)

Incidence, Prevalence, and Mortality of People with Psoriasis and Psoriatic Arthritis in Taiwan: A Nationwide Cohort Study
por: ISKANDAR, Ireny Y. K., et al.
Publicado: (2022)

Long‐term, durable, absolute Psoriasis Area and Severity Index and health‐related quality of life improvements with risankizumab treatment: a post hoc integrated analysis of patients with moderate‐to‐severe plaque psoriasis
por: Gooderham, M., et al.
Publicado: (2022)

CARD14 mutations may predict response to antitumour necrosis factor‐α therapy in psoriasis: a potential further step towards personalized medicine
por: Wu, K.C.P., et al.
Publicado: (2016)

Editorial: fixed‐dose combination calcipotriol/betamethasone dipropionate foam in the treatment of patients with psoriasis
por: Lebwohl, M., et al.
Publicado: (2021)

The top 10 research priorities for psoriasis in the U.K.: results of a James Lind Alliance psoriasis Priority Setting Partnership
por: Majeed‐Ariss, R., et al.
Publicado: (2019)

What are the barriers to physical activity in patients with chronic plaque psoriasis?
por: Auker, L., et al.
Publicado: (2020)

Paradoxical eczema in patients with psoriasis receiving biologics: a case series
por: Al‐Janabi, Ali, et al.
Publicado: (2022)

The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository
por: Lecaros, C., et al.
Publicado: (2021)

Safety of selective IL‐23p19 inhibitors for the treatment of psoriasis
por: Crowley, J.J., et al.
Publicado: (2019)

Addressing challenges associated with long‐term topical treatment and benefits of proactive management in patients with psoriasis
por: Lebwohl, M., et al.
Publicado: (2021)

‘Mind the gap’: what patients and clinicians believe is ‘unknown’ about psoriasis
por: Majeed‐Ariss, R., et al.
Publicado: (2020)

Drug survival of biologic therapy in a large, disease‐based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
por: Menter, A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4vj1vprqtfmikijfjf56ksbrob